Key Facts
This company profile is a search result of implisense.com
Website
https://www.novartum.com/Phone
+49 911 225060Products and Services
SoftwareSoftwareentwicklungOptimierungSize (Revenue & Employees)
Micro-sized companyBalance sheet total
1 M €Legal Form
Gesellschaft mit beschränkter HaftungCommercial Register
FürthHRB 17633
Legal Entity Identifier (LEI)
—Incorporation
Capital Stock
Historical Names
Address
Finkenstr. 4, 90762 Fürth
Order Implisense Plus now for full company profiles and complete functionality! Your benefits:
- Real-time search for contact persons
- Complete annual reports
- More search filters and results
Customer Relationship Intelligence: The Key to Optimizing your Sales Processes
Use our AI-powered assistants to identify the right companies, track current developments and market changes, reach relevant decision-makers and perfect your sales strategy with data-based insights. All seamlessly integrated into your CRM.
- Find the right companies
- Keep an eye on your target companies
- Reach the right decision-makers
- Increase your closing rate
Executive Summary
Implisense Assist gives you the opportunity to use AI to find out about companies via chat, analyze them and much more. We from the Implisense team also provide you with ready-made analyses, e.g., an executive summary and a financial analysis. Just try it out for yourself!
Implisense Plus
Contacts
Search for contact persons and decision-makers in real time with our AI-supported GDPR-compliant solution.
- H•••••••• H••••
Key Figures
AnalysisAnalysis with Implisense Assist
Create an AI analysis of the balance sheet with Implisense Assist.
See directly all available financial statements of this company.
+27.2%
€ 777,242.00
€ 988,325.00
The key figures on balance sheet total, revenue, profit and number of employees were generated by a fully automatic extraction from published annual financial statements. The last published balance sheet total of the Novartum GmbH is 2022 at 1 M €. The difference compared to the previous year is +27.2%.
1 Employees
The key figures on balance sheet total, revenue, profit and number of employees were generated by a fully automatic extraction from published annual financial statements.
| Total Assets in € | 2022 | 2021 |
|---|---|---|
| Fixed Assets | ||
| Current Assets | ||
| Receivables | ||
| Cash and Cash Equivalents | ||
| Sum of Total Assets |
| Total Liabilities in € | 2022 | 2021 |
|---|---|---|
| Equity | ||
| Net Income | ||
| Obligations | ||
| Accruals | ||
| Sum of Total Liabilities |
Timeline
Network
Discover connections between companies via managers, shareholdings, links or addresses here.
Register to see more connections via management and web links. Get access to an interactive network to better understand the environment of this company.
Show moreProducts & Technologies
Novartum GmbH is mentioned in public sources in the context of the following products and services. Software, Softwareentwicklung and Optimierung are the most common. The ranking list shown is without guarantee of completeness or correctness.
The following software solutions, technologies and concepts are often referenced in job postings and press releases of Novartum GmbH. Most frequently recognized were Automation Technology, Userlike and SQL.
Information for Job Seekers
Based on job advertisements of Novartum GmbH, the following specific requirements for job seekers were identified more frequently. Specific requirements can be found in the latest published job advertisements.
Persönliche Kompetenz
Soziale Kompetenz
The following benefits were repeatedly recognized in job postings of Novartum GmbH. This data is supplied without liability and intended for orientation purposes only.
Register now for a free Implisense account. Registered users have access to advanced analyses and more key figures on company profiles, receive more extensive search results and can also create and manage their own favorites.
- Richer Company Profiles
- Expanded Search Results
- Personal Favourites
